NCT04227249View on ClinicalTrials.gov

3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

153

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2027

Conditions

Endometrial Cancer

Interventions

PROCEDURE

no lymph node dissection

do not undergo lymph node dissection

All Listed Sponsors

lead

Seoul National University Hospital

OTHER